Researchers across the globe face common barriers in translational research that can delay the development of new interventions for patients in need.
This seminar, presented by Dr Niamh Kinsella on 2 July 2019 in Cambridge, will focus on describing the strategies and benefits of implementing a stage-gate approach for Phase 1 clinical development.
- Clear go no-go decision points
- Higher probability of success with Phase 1 submissions
- Clear and favourable exit strategies
With 20 years of experience from biologics development, Dr. Niamh Kinsella provides tangible and actionable advice to optimise early drug development plans.
12:00 Registration and complimentary lunch
12:30 Welcome: Andrew Monaghan, General Manager NDA UK
12:40 Presentation: Navigating the Regulatory Maze – Dr Niamh Kinsella
13:30 Question and answer session
13:50 Concluding remarks
14:00 Coffee and mingle
Take the opportunity to book a 20 min slot to speak directly with our experts.
Email: email@example.com to book your time now.
Date: 2nd July 2019
Time: 12:00 – 14:00 (with the opportunity to book 1-1 meetings afterwards)
Venue: Queen Edith’s Room, The Cambridge Building, Babraham Research Campus, Cambridge
The seminar will be an open and interactive workshop with the opportunity to ask questions. Specific questions can be sent in advance to firstname.lastname@example.org
Registration: RSVP by Friday 28th June 2019 to email@example.com
Contact: Anna Perrin, Marketing Assistant, +44 (0) 1372 860 623
If you are unable to attend, please advise us no later than two days before the seminar.
We look forward to seeing you there!
VP Early Stage Development